Switzerland
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 217.83 B
|
Dec. 31, 2023 | USD 4.49 | 1.09% |
|
Switzerland |
|
2 |
USD 110.88 B
|
Dec. 31, 2023 | USD 81.24 | 0.39% |
|
Switzerland |
|
3 |
USD 74.69 B
|
Dec. 31, 2023 | USD 579.92 | 1.30% |
|
Switzerland |
|
4 |
USD 71.79 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
5 |
USD 49.83 B
|
Dec. 31, 2023 | USD 265.51 | 1.43% |
|
Switzerland |
|
6 |
USD 49.73 B
|
Dec. 31, 2023 | USD 144.92 | 1.42% |
|
Switzerland |
|
7 |
USD 46.66 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
8 |
USD 39.06 B
|
Dec. 31, 2023 | USD 32.18 | 0.77% |
|
Switzerland |
|
9 |
USD 32.23 B
|
Dec. 31, 2023 | USD 53.62 | 1.16% |
|
Switzerland |
|
10 |
USD 32.08 B
|
Dec. 31, 2023 | USD 92.83 | 1.00% |
|
Switzerland |
|
11 |
USD 28.33 B
|
Dec. 31, 2023 | USD 219.08 | -0.15% |
|
Switzerland |
|
12 |
USD 26.44 B
|
Dec. 31, 2023 | USD 22.70 | 0.40% |
|
Switzerland |
|
13 |
USD 22.24 B
|
March 31, 2024 | USD 153.58 | 1.77% |
|
Switzerland |
|
14 |
USD 18.10 B
|
Dec. 31, 2023 | USD 774.90 | 1.41% |
|
Switzerland |
|
15 |
USD 17.29 B
|
Dec. 31, 2023 | USD 24.18 | 0.86% |
|
Switzerland |
|
16 |
USD 15.85 B
|
Sept. 27, 2024 | USD 142.90 | 1.23% |
|
Switzerland |
|
17 |
USD 15.19 B
|
Dec. 31, 2023 | USD 39.02 | 1.58% |
|
Switzerland |
|
18 |
USD 13.65 B
|
Dec. 31, 2023 | USD 269.69 | 0.74% |
|
Switzerland |
|
19 |
USD 13.64 B
|
June 30, 2024 | USD 9.52 | NA |
|
Switzerland |
|
20 |
USD 13.35 B
|
Dec. 31, 2023 | USD 239.68 | 1.14% |
|
Switzerland |
|
21 |
USD 13.15 B
|
Dec. 31, 2023 | USD 555.93 | 0.50% |
|
Switzerland |
|
22 |
USD 13.14 B
|
Dec. 31, 2023 | USD 73.83 | -0.24% |
|
Switzerland |
|
23 |
USD 12.22 B
|
Aug. 31, 2024 | USD 1.19 K | -0.60% |
|
Switzerland |
|
24 |
USD 11.73 B
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
25 |
USD 11.24 B
|
Dec. 31, 2023 | USD 33.06 | -0.86% |
|
Switzerland |
|
26 |
USD 10.99 B
|
Dec. 31, 2023 | USD 245.37 | 0.95% |
|
Switzerland |
|
27 |
USD 10.96 B
|
Dec. 31, 2023 | USD 170.56 | 1.67% |
|
Switzerland |
|
28 |
USD 9.98 B
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
29 |
USD 9.46 B
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
30 |
USD 9.37 B
|
Dec. 31, 2023 | USD 170.50 | 0.27% |
|
Switzerland |
|
31 |
USD 8.36 B
|
Dec. 31, 2023 | USD 179.21 | -0.05% |
|
Switzerland |
|
32 |
USD 8.21 B
|
Dec. 31, 2023 | USD 4.22 K | -0.46% |
|
Switzerland |
|
33 |
USD 7.98 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
34 |
USD 7.87 B
|
Dec. 31, 2023 | USD 101.48 | 0.63% |
|
Switzerland |
|
35 |
USD 6.18 B
|
Dec. 31, 2023 | USD 11.25 K | 5.32% |
|
Switzerland |
|
36 |
USD 5.36 B
|
Dec. 31, 2023 | USD 285.36 | -1.95% |
|
Switzerland |
|
37 |
USD 5.26 B
|
Dec. 31, 2023 | USD 168.26 | 0.36% |
|
Switzerland |
|
38 |
USD 5.23 B
|
Dec. 30, 2023 | USD 212.27 | 1.84% |
|
Switzerland |
|
39 |
USD 5.20 B
|
Dec. 31, 2023 | USD 10.82 | -1.30% |
|
Switzerland |
|
40 |
USD 5.04 B
|
Dec. 31, 2023 | USD 778.84 | 0.50% |
|
Switzerland |
|
41 |
USD 4.78 B
|
Dec. 31, 2023 | USD 74.16 | 1.17% |
|
Switzerland |
|
42 |
USD 4.45 B
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
43 |
USD 4.30 B
|
March 31, 2024 | USD 86.74 | 2.15% |
|
Switzerland |
|
44 |
USD 4.29 B
|
Dec. 31, 2023 | USD 21.51 | -0.52% |
|
Switzerland |
|
45 |
USD 4.27 B
|
Dec. 31, 2023 | USD 32.37 | -1.99% |
|
Switzerland |
|
46 |
USD 4.25 B
|
Dec. 31, 2023 | USD 351.63 | 0.18% |
|
Switzerland |
|
47 |
USD 4.11 B
|
Dec. 31, 2023 | USD 119.18 | 2.21% |
|
Switzerland |
|
48 |
USD 4.02 B
|
March 31, 2024 | USD 329.06 | 0.76% |
|
Switzerland |
|
49 |
USD 3.90 B
|
Dec. 31, 2023 | USD 147.22 | -0.10% |
|
Switzerland |
|
50 |
USD 3.89 B
|
Dec. 31, 2023 | USD 9.38 | 1.96% |
|
Switzerland |
The company in Switzerland with the highest Revenue is Glencore plc (LSE: GLEN.L) at USD 217.83 B.
The company in Switzerland with the lowest Revenue is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at USD 0.00.
The top 10 companies in Switzerland by Revenue are Glencore plc, Nestlé S.A., Zurich Insurance Group AG, Roche Holding AG, Chubb Limited, Swiss Re AG, Novartis AG, UBS Group AG, ABB Ltd and Holcim Ltd.
The bottom 10 companies in Switzerland by Revenue are MoonLake Immunotherapeutics, NLS Pharmaceutics AG, Oculis Holding AG, Alpine Select AG, Addex Therapeutics Ltd, Molecular Partners AG, Valartis Group AG, Züblin Immobilien Holding AG, TalkPool AG and AC Immune SA.